Prof. Xavier Pivot, University Hospital of Besançon, France
Channel: Oncoletter
Date: 01/10/2012

Vienna, ESMO 2012, Pressconference October 1:
Prof. Xavier Pivot, University Hospital of Besançon, France: PHARE Trial results comparing 6 to 12 months of trastuzumab in adjuvant early breast cancer